{"name":"Fidelity Biosciences","permalink":"fidelity-biosciences-2","crunchbase_url":"http://www.crunchbase.com/financial-organization/fidelity-biosciences-2","homepage_url":"http://www.fidelitybiosciences.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617-231-2400","description":"","email_address":"FidelityBiosciences@fmr.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Mon Jun 22 07:40:47 UTC 2009","updated_at":"Mon Jun 22 07:49:12 UTC 2009","overview":"<p>They are a division of Fidelity Investments, one of the worldâ€™s leading providers of financial services. For more than 30 years, Fidelity Investments has been a significant presence in the venture capital and private equity industry, investing the firms own capital since 1969. This provides them with the flexibility, and capabilities of traditional venture capital firms while eliminating the additional pressures of fundraising. The result is a clear focus on building long-term value for Fidelity, their management partners, and co-investors.</p>","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0044/50044v1-max-150x150.png"],[[233,79],"assets/images/resized/0005/0044/50044v1-max-250x250.png"],[[233,79],"assets/images/resized/0005/0044/50044v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"1 Main Street","address2":"13th Floor","zip_code":"02142","city":"Cambridge","state_code":"MA","country_code":"USA","latitude":42.36226,"longitude":-71.080168}],"relationships":[{"is_past":false,"title":"Chief Financial Officer","person":{"first_name":"Richard","last_name":"W. Fedorowich Jr.","permalink":"richard-w-fedorowich-jr","image":{"available_sizes":[[[99,150],"assets/images/resized/0005/0054/50054v1-max-150x150.jpg"],[[166,250],"assets/images/resized/0005/0054/50054v1-max-250x250.jpg"],[[167,251],"assets/images/resized/0005/0054/50054v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Partner","person":{"first_name":"Stephen","last_name":"Knight","permalink":"stephen-knight","image":{"available_sizes":[[[99,150],"assets/images/resized/0005/0048/50048v1-max-150x150.jpg"],[[166,250],"assets/images/resized/0005/0048/50048v1-max-250x250.jpg"],[[167,251],"assets/images/resized/0005/0048/50048v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"Robert","last_name":"Weisskoff","permalink":"robert-weisskoff","image":{"available_sizes":[[[99,150],"assets/images/resized/0005/0053/50053v1-max-150x150.jpg"],[[166,250],"assets/images/resized/0005/0053/50053v1-max-250x250.jpg"],[[167,251],"assets/images/resized/0005/0053/50053v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.reuters.com/article/idUS91076+25-Aug-2008+BW20080825","source_description":"Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":25,"company":{"name":"Proteostasis Therapeutics","permalink":"proteostasis-therapeutics","image":{"available_sizes":[[[150,46],"assets/images/resized/0005/0038/50038v2-max-150x150.png"],[[250,77],"assets/images/resized/0005/0038/50038v2-max-250x250.png"],[[374,116],"assets/images/resized/0005/0038/50038v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/accuri-cytometers-inc-series-d-4m/","source_description":"Accuri Cytometers, Inc.: Series D $4M","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":10,"company":{"name":"Accuri Cytometers","permalink":"accuri-cytometers","image":{"available_sizes":[[[150,75],"assets/images/resized/0005/6034/56034v1-max-150x150.png"],[[191,96],"assets/images/resized/0005/6034/56034v1-max-250x250.png"],[[191,96],"assets/images/resized/0005/6034/56034v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/tetraphase-hauls-45m-c-round-back-antibiotic-work/2010-06-01?utm_medium=rss&utm_source=rss","source_description":"Tetraphase hauls in $45M C round to back antibiotic work","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":1,"company":{"name":"Tetraphase Pharmaceuticals","permalink":"tetraphase-pharmaceuticals","image":{"available_sizes":[[[150,25],"assets/images/resized/0003/2808/32808v1-max-150x150.png"],[[250,41],"assets/images/resized/0003/2808/32808v1-max-250x250.png"],[[251,42],"assets/images/resized/0003/2808/32808v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/foldrx-banks-29m-neurodegenerative-drug-application/2010-06-15?utm_medium=rss&utm_source=rss","source_description":"FoldRx banks $29M for neurodegenerative drug application","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":15,"company":{"name":"Foldrx Pharmaceuticals","permalink":"foldrx-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://vicepttx.com/pdf/Vicept%20Release%20Completes%20Series%20A%206.30.10.pdf","source_description":"Vicept Therapeutics Secures $10 Million to Complete Series A Funding","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":30,"company":{"name":"Vicept Therapeutics","permalink":"vicept-therapeutics","image":{"available_sizes":[[[150,90],"assets/images/resized/0009/2197/92197v1-max-150x150.png"],[[185,112],"assets/images/resized/0009/2197/92197v1-max-250x250.png"],[[185,112],"assets/images/resized/0009/2197/92197v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.mersana.com/news-events/news_11-08-05_mersana-21million-financing.pdf","source_description":"Mersana Therapeutics, Inc. Completes $21 Million Financing","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":8,"company":{"name":"Mersana Therapeutics","permalink":"mersana-therapeutics","image":{"available_sizes":[[[150,60],"assets/images/resized/0009/2309/92309v1-max-150x150.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-250x250.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.viewray.com/news/ViewRay_SeriesCfunding_25Aug2010.pdf","source_description":"ViewRay Secures Series C Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":25,"company":{"name":"ViewRay","permalink":"viewray","image":null}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/accuri-cytometers-inc-series-e-6m/","source_description":"Accuri Cytometers, Inc.: Series E $6M","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":19,"company":{"name":"Accuri Cytometers","permalink":"accuri-cytometers","image":{"available_sizes":[[[150,75],"assets/images/resized/0005/6034/56034v1-max-150x150.png"],[[191,96],"assets/images/resized/0005/6034/56034v1-max-250x250.png"],[[191,96],"assets/images/resized/0005/6034/56034v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/01/nextwave-pharmaceuticals-raises-45m-in.html","source_description":"NextWave Pharmaceuticals Raises $45m in a Series C Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":11,"company":{"name":"NextWave Pharmaceuticals","permalink":"nextwave-pharmaceuticals","image":{"available_sizes":[[[150,89],"assets/images/resized/0011/6922/116922v1-max-150x150.jpg"],[[217,130],"assets/images/resized/0011/6922/116922v1-max-250x250.jpg"],[[217,130],"assets/images/resized/0011/6922/116922v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/06/ultragenyx-pharmaceutical-closes-45m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Ultragenyx Pharmaceutical Closes $45M Series A Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":20,"company":{"name":"Ultragenyx Pharmaceutical","permalink":"ultragenyx-pharmaceutical","image":{"available_sizes":[[[150,57],"assets/images/resized/0014/0132/140132v1-max-150x150.png"],[[210,80],"assets/images/resized/0014/0132/140132v1-max-250x250.png"],[[210,80],"assets/images/resized/0014/0132/140132v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fluidnet.net/downloads/Fluidnet-Series-C-Release.pdf","source_description":"FLUIDNET CORPORATION COMPLETES $25 MILLION SERIES C FINANCING","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":16,"company":{"name":"Fluidnet","permalink":"fluidnet","image":{"available_sizes":[[[150,70],"assets/images/resized/0009/9205/99205v1-max-150x150.png"],[[184,86],"assets/images/resized/0009/9205/99205v1-max-250x250.png"],[[184,86],"assets/images/resized/0009/9205/99205v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://wraltechwire.com/business/tech_wire/medcity/story/10066279/","source_description":"MRI-guided radiotherapy firm ViewRay gets $10M in new funding","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":2,"company":{"name":"ViewRay","permalink":"viewray","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.businesswire.com/news/home/20111019006928/en/Imagen-Biotech-Secures-40-Million-Advance-Ophthalmology","source_description":"Imagen Biotech Secures Up to $40 Million to Advance Ophthalmology Therapies","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":19,"company":{"name":"Imagen Biotech","permalink":"imagen-biotech","image":{"available_sizes":[[[150,62],"assets/images/resized/0015/8856/158856v1-max-150x150.jpg"],[[250,104],"assets/images/resized/0015/8856/158856v1-max-250x250.jpg"],[[402,168],"assets/images/resized/0015/8856/158856v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/03/viewray-closes-45m-series-venture-capital-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"ViewRay Closes $45M Series C Venture Capital Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":13,"company":{"name":"ViewRay","permalink":"viewray","image":null}}},{"funding_round":{"round_code":"d","source_url":"http://www.liazon.com/blog/stories/Story.aspx?id=10042","source_description":"Liazon Closes $18.2M in Funding to Expand Private Benefits Exchange","raised_amount":18200000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":24,"company":{"name":"Liazon","permalink":"liazon","image":{"available_sizes":[[[150,72],"assets/images/resized/0012/9319/129319v5-max-150x150.jpg"],[[250,120],"assets/images/resized/0012/9319/129319v5-max-250x250.jpg"],[[275,133],"assets/images/resized/0012/9319/129319v5-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.blueprintmedicines.com/pdf/Blueprint-Launch-PR.pdf","source_description":"Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":11,"company":{"name":"Blueprint Medicines","permalink":"blueprint-medicines","image":{"available_sizes":[[[150,31],"assets/images/resized/0013/0131/130131v1-max-150x150.png"],[[250,52],"assets/images/resized/0013/0131/130131v1-max-250x250.png"],[[300,63],"assets/images/resized/0013/0131/130131v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/07/mersana-therapeutics-raises-27m-series-a-1-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Mersana Therapeutics Raises $27M in Series A-1 Financing","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":31,"company":{"name":"Mersana Therapeutics","permalink":"mersana-therapeutics","image":{"available_sizes":[[[150,60],"assets/images/resized/0009/2309/92309v1-max-150x150.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-250x250.jpg"],[[195,78],"assets/images/resized/0009/2309/92309v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"seed","source_url":"http://techcrunch.com/2012/08/03/procured-health-raise/","source_description":"Procured Health Nabs $1.1M From Bessemer, Athena Health Founder To Help Reduce Health Costs ","raised_amount":1100000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":3,"company":{"name":"Procured Health","permalink":"procured-health","image":{"available_sizes":[[[150,36],"assets/images/resized/0019/9060/199060v2-max-150x150.png"],[[250,59],"assets/images/resized/0019/9060/199060v2-max-250x250.png"],[[450,107],"assets/images/resized/0019/9060/199060v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/10/aclaris-therapeutics-secures-21m-series-financing.html","source_description":"Aclaris Therapeutics Secures $21M in Series A Financing","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":24,"company":{"name":"Aclaris Therapeutics","permalink":"aclaris-therapeutics","image":{"available_sizes":[[[150,66],"assets/images/resized/0021/7161/217161v1-max-150x150.jpg"],[[211,94],"assets/images/resized/0021/7161/217161v1-max-250x250.jpg"],[[211,94],"assets/images/resized/0021/7161/217161v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercepharmamanufacturing.com/press-releases/innovent-biologics-adds-25-million-expand-its-antibody-pipeline-and-its-man","source_description":"Innovent Biologics Adds $25 Million to Expand its Antibody Pipeline and its Manufacturing Capabilities","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":16,"company":{"name":"Innovent Biologics","permalink":"innovent-biologics","image":{"available_sizes":[[[150,41],"assets/images/resized/0022/1443/221443v1-max-150x150.jpg"],[[250,69],"assets/images/resized/0022/1443/221443v1-max-250x250.jpg"],[[302,84],"assets/images/resized/0022/1443/221443v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}